| 2024-08-28 |
[Clinical Picture] Multimodality imaging of a large incidental papillary fibroelastoma |
Wiaam Elkhatib, Prajwal Reddy |
|
| 2024-08-28 |
[Editorial] Legacies of conflict and humanitarian crises on cancer care |
The Lancet Oncology |
|
| 2024-08-28 |
[Policy Review] Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup |
Carien L Creutzberg, Jae-Weon Kim, Gemma Eminowicz, Emma Allanson, Lauriane Eberst, Se Ik Kim, Remi A Nout, Jeong-Yeol Park, Domenica Lorusso, Linda Mileshkin, Petronella B Ottevanger, Alison Brand, Delia Mezzanzanica, Amit Oza, Val Gebski, Bhavana Pothur |
|
| 2024-08-28 |
[Review] The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect group |
Philipp Karschnia, Jasper K W Gerritsen, Nico Teske, Daniel P Cahill, Asgeir S Jakola, Martin van den Bent, Michael Weller, Oliver Schnell, Einar O Vik-Mo, Niklas Thon, Arnaud J P E Vincent, Michelle M Kim, Guido Reifenberger, Susan M Chang, Shawn L Herve |
|
| 2024-08-28 |
[Correspondence] Enhancing cardiovascular disease risk management in childhood cancer survivors |
Fei Liu, Qing Lan, Long Guo |
|
| 2024-08-28 |
[Corrections] Correction to Lancet Oncol 2023; 24: 733–43 |
|
|
| 2024-08-28 |
[Correspondence] Enhancing equity and long-term impact assessments in radiotherapy environmental studies |
Guang Yang, Jun Dou |
|
| 2024-08-28 |
[Correspondence] Enhancing cardiovascular disease risk management in childhood cancer survivors |
Lan Yang, Jinlong Jiang, Shijie Guo |
|
| 2024-08-28 |
[Comment] Contextualising legal and ethical conundrums of artificial intelligence in oncology |
Ghada Zakout |
|
| 2024-08-28 |
[Correspondence] Enhancing equity and long-term impact assessments in radiotherapy environmental studies |
Xiang Li, Guo-Bao Huang |
|
| 2024-08-28 |
[Policy Review] Defining the quality of interdisciplinary care for patients with brain metastases: modified Delphi panel recommendations |
Camilo E Fadul, Jason P Sheehan, Julio Silvestre, Gloribel Bonilla, Joseph A Bovi, Manmeet Ahluwalia, Riccardo Soffietti, David Hui, Roger T Anderson |
|
| 2024-08-28 |
[Policy Review] Translating the theranostic concept to neuro-oncology: disrupting barriers |
Nathalie L Albert, Emilie Le Rhun, Giuseppe Minniti, Maximilian J Mair, Norbert Galldiks, Nelleke Tolboom, Asgeir S Jakola, Maximilian Niyazi, Marion Smits, Antoine Verger, Francesco Cicone, Michael Weller, Matthias Preusser, European Organisation for Res |
|
| 2024-08-28 |
[Personal View] Improving individualised therapies in localised gastro-oesophageal adenocarcinoma |
Magali Svrcek, Thibault Voron, Thierry André, Elizabeth C Smyth, Christelle de la Fouchardière |
|
| 2024-08-28 |
[Articles] Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial |
Mafalda Oliveira, Hope S Rugo, Sacha J Howell, Florence Dalenc, Javier Cortes, Henry L Gomez, Xichun Hu, Masakazu Toi, Komal Jhaveri, Petr Krivorotko, Sibylle Loibl, Serafin Morales Murillo, Meena Okera, Zbigniew Nowecki, Yeon Hee Park, Joo Hyuk Sohn, Eri |
|
| 2024-08-28 |
[News] Peru advances towards universal health care for patients with cancer |
Talha Burki |
|
| 2024-08-28 |
[News] Progress in NCD screening in Mongolia |
Sharmila Devi |
|
| 2024-08-28 |
[Perspectives] Ending financial discrimination for cancer survivors: embedding the Right to be Forgotten in legislation across Europe |
Mark Lawler, Grazia Scocca, Françoise Meunier |
|
| 2024-08-28 |
[Articles] Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): long-term, health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial |
Emanuel Bührer, Michal Kicinski, Mario Mandala, Madeline Pe, Georgina V Long, Victoria Atkinson, Christian U Blank, Andrew Haydon, Stéphane Dalle, Adnan Khattak, Matteo S Carlino, Andrey Meshcheryakov, Shahneen Sandhu, Susana Puig, Dirk Schadendorf, Rahim |
|
| 2024-08-28 |
[Comment] Measuring success of adjuvant treatment for patients with melanoma |
Brent O'Carrigan, Pippa G Corrie |
|
| 2024-08-28 |
[Articles] Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7–IFCT-1402): a multicentre, randomised, controlled phas |
Pierre Vera, Sébastien Thureau, Florence Le Tinier, Philippe Chaumet-Riffaud, Sébastien Hapdey, Hélène Kolesnikov-Gauthier, Etienne Martin, Alina Berriolo-Riedinger, Nicolas Pourel, Jean Marc Broglia, Pierre Boissellier, Sophie Guillemard, Naji Salem, Isa |
|
| 2024-08-28 |
[News] Disappointment facing patients with breast cancer as trastuzumab deruxtecan too expensive for NHS |
Elizabeth Gourd |
|
| 2024-08-28 |
[Articles] Discontinuation versus continuation of imatinib in patients with advanced gastrointestinal stromal tumours (BFR14): exploratory long-term follow-up of an open-label, multicentre, randomised, phase 3 trial |
Jean-Yves Blay, Quentin Devin, Florence Duffaud, Maud Toulmonde, Nelly Firmin, Olivier Collard, Emmanuelle Bompas, Benjamin Verret, Isabelle Ray-Coquard, Sebastien Salas, Clemence Henon, Charles Honoré, Mehdi Brahmi, Armelle Dufresne, Marc Pracht, Alice H |
|
| 2024-08-28 |
[Articles] Postoperative radiotherapy in women with early operable breast cancer (Scottish Breast Conservation Trial): 30-year update of a randomised, controlled, phase 3 trial |
Linda J Williams, Ian H Kunkler, Karen J Taylor, Joanna Dunlop, Tammy Piper, Jacqueline Caldwell, Wilma Jack, Joseph F Loane, Kenneth Elder, John M S Bartlett, J Michael Dixon, David A Cameron |
|
| 2024-08-28 |
[Comment] Who does not benefit from whole-breast radiotherapy and how to find them? |
Hans-Christian Kolberg, Cornelia Kolberg-Liedtke |
|
| 2024-08-28 |
[Comment] Imatinib in advanced GIST: if it's working, don’t stop a good thing |
Ryan A Denu, Neeta Somaiah |
|
| 2024-08-28 |
[Articles] Cancer incidence and survival for 11 cancers in the Commonwealth: a simulation-based modelling study |
Zachary J Ward, Qassi Gaba, Rifat Atun |
|
| 2024-08-28 |
[Articles] Completion axillary lymph node dissection for the identification of pN2–3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial |
Jana de Boniface, Matilda Appelgren, Robert Szulkin, Sara Alkner, Yvette Andersson, Leif Bergkvist, Jan Frisell, Oreste Davide Gentilini, Michalis Kontos, Thorsten Kühn, Dan Lundstedt, Birgitte Vrou Offersen, Roger Olofsson Bagge, Toralf Reimer, Malin Sun |
|
| 2024-08-28 |
[Comment] Time to abandon axillary lymph node dissection in early-stage breast cancer |
Andrea V Barrio |
|
| 2024-08-28 |
[Articles] Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial |
Kanwal Raghav, Salvatore Siena, Atsuo Takashima, Takeshi Kato, Marc Van den Eynde, Filippo Pietrantonio, Yoshito Komatsu, Hisato Kawakami, Marc Peeters, Thierry Andre, Sara Lonardi, Kensei Yamaguchi, Jeanne Tie, Cristina Gravalos Castro, Hung-Chih Hsu, Jo |
|
| 2024-08-28 |
[Comment] Trastuzumab deruxtecan in HER2-positive metastatic colorectal cancer: less is more? |
Jeanine M L Roodhart, Miriam Koopman |
|
| 2024-08-28 |
[Articles] Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial |
Nicoletta Colombo, Elena Biagioli, Kenichi Harano, Francesca Galli, Emma Hudson, Yoland Antill, Chel Hun Choi, Manuela Rabaglio, Frederic Marmé, Christian Marth, Gabriella Parma, Lorena Fariñas-Madrid, Shin Nishio, Karen Allan, Yeh Chen Lee, Elisa Piovano |
|
| 2024-08-28 |
[News] New immigration laws could undermine cancer research in the UK |
Karl Gruber |
|
| 2024-08-28 |
[News] Poor progress on reducing alcohol consumption in Europe |
Talha Burki |
|
| 2024-08-28 |
[Articles] Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study |
Madeleine J Karpinski, Johannes Hüsing, Kevin Claassen, Lennart Möller, Hiltraud Kajüter, Florian Oesterling, Viktor Grünwald, Lale Umutlu, Jens Kleesiek, Tugce Telli, Anja Merkel-Jens, Anika Hüsing, Claudia Kesch, Ken Herrmann, Matthias Eiber, Sebastian |
|
| 2024-08-28 |
[Comment] Use of PROMISE criteria on PSMA-PET for prediction of overall survival in prostate cancer |
Kirsten Bouchelouche, Peter L Choyke |
|
| 2024-08-28 |
[News] Improving cancer control initiatives in Indigenous people |
Karl Gruber |
|
| 2024-08-28 |
[News] Over US$100 million pledged to improve cancer care across Africa |
Paul Adepoju |
|
| 2024-07-30 |
[Clinical Picture] Primary cardiac angiosarcoma presenting as restrictive cardiomyopathy |
Joshua M Peterson, Adam Gonzalez, Juan P Olano, Suimin Qiu, Tejo Musunuru, Kirill A Lyapichev |
|
| 2024-07-30 |
[Editorial] Incorporating whole-genome sequencing into cancer care |
The Lancet Oncology |
|
| 2024-07-30 |
[Perspectives] Two-physician certification in end-of-life decision making |
Abigail P Sneider, Valerie Gutmann Koch, Andrew Hantel, Peter Angelos |
|
| 2024-07-30 |
[Corrections] Correction to Lancet Oncol 2024; 25: e374–87 |
|
|
| 2024-07-30 |
[Articles] Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial |
Yi-Long Wu, Valentina Guarneri, Pei Jye Voon, Boon Khaw Lim, Jin-Ji Yang, Marie Wislez, Cheng Huang, Chong Kin Liam, Julien Mazieres, Lye Mun Tho, Hidetoshi Hayashi, Nguyen Viet Nhung, Puey Ling Chia, Filippo de Marinis, Jo Raskin, Qinghua Zhou, Giovanna |
|
| 2024-07-30 |
[Correspondence] Evaluating the KEYNOTE-057 trial's findings: addressing demographic, methodological, and economic considerations |
Shen Wang |
|
| 2024-07-30 |
[Corrections] Correction to Lancet Oncol 2024; 25: e250–59 |
|
|
| 2024-07-30 |
[Correspondence] Challenges and prospects for cancer treatment in prison settings |
Feng Zhang |
|
| 2024-07-30 |
[Correspondence] Sotorasib versus docetaxel: evidence supporting CodeBreaK 200 |
Luis Paz-Ares, Bhakti Mehta, Yang Wang, David Waterhouse, Adrianus Johannes de Langen |
|
| 2024-07-30 |
[Review] Dose selection of novel anticancer drugs: exposing the gap between selected and required doses |
Catharina J P Op ‘t Hoog, Niven Mehra, Marc Maliepaard, Kalijn Bol, Hans Gelderblom, Gabe S Sonke, Adrianus J de Langen, Niels W C J van de Donk, Jeroen J W M Janssen, Monique C Minnema, Nielka P van Erp, Emmy Boerrigter |
|
| 2024-07-30 |
[Correspondence] Challenges and prospects for cancer treatment in prison settings |
Hujian Hong, Yanli Qu |
|
| 2024-07-30 |
[Review] Radiotherapy, immunity, and immune checkpoint inhibitors |
Connor Lynch, Sean P Pitroda, Ralph R Weichselbaum |
|
| 2024-07-30 |
[Perspectives] Together and apart: experiences of childhood brain tumour |
Kate Young, Christine Cashion, Natalie Bradford |
|
| 2024-07-30 |
[Comment] Molecular diagnosis and site-specific therapy in cancer of unknown primary: an important milestone |
F Anthony Greco, Chris Labaki, Elie Rassy |
|
| 2024-07-30 |
[Articles] Site-specific therapy guided by a 90-gene expression assay versus empirical chemotherapy in patients with cancer of unknown primary (Fudan CUP-001): a randomised controlled trial |
Xin Liu, Xiaowei Zhang, Shiyu Jiang, Miao Mo, Qifeng Wang, Yanli Wang, Liangping Zhou, Silong Hu, Huijuan Yang, Yifeng Hou, Yong Chen, Xueguan Lu, Yu Wang, Xiaoyan Zhou, Wentao Li, Cai Chang, Xiujiang Yang, Ke Chen, Jun Cao, Qinghua Xu, Yifeng Sun, Jianfe |
|
| 2024-07-30 |
[News] Lifestyle factors driving cancer cases and mortality in the USA |
Karl Gruber |
|
| 2024-07-30 |
[News] Call for stricter tobacco control laws in Ghana |
Manjulika Das |
|
| 2024-07-30 |
[News] Impact of pharmacy benefit managers on cancer health care |
Priya Venkatesan |
|
| 2024-07-30 |
[Articles] Celiac plexus radiosurgery for pain management in advanced cancer: a multicentre, single-arm, phase 2 trial |
Yaacov R Lawrence, Marcin Miszczyk, Laura A Dawson, Dayssy Alexandra Diaz Pardo, Artur Aguiar, Dror Limon, Raphael M Pfeffer, Michael Buckstein, Aisling S Barry, Tikva Meron, Adam P Dicker, Jerzy Wydmański, Camilla Zimmermann, Ofer Margalit, David Hausner |
|
| 2024-07-30 |
[Comment] Alleviating retroperitoneal pain with celiac plexus radiosurgery |
Daniel Moore-Palhares, Sylvia S W Ng, Alexander V Louie |
|
| 2024-07-30 |
[Articles] Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study |
Guihong Wan, Wenxin Chen, Sara Khattab, Katie Roster, Nga Nguyen, Boshen Yan, Ahmad Rajeh, Jayhyun Seo, Hannah Rashdan, Leyre Zubiri, Matthew J Hadfield, Shadmehr Demehri, Kun-Hsing Yu, William Lotter, Alexander Gusev, Nicole R LeBoeuf, Kerry L Reynolds, |
|
| 2024-07-30 |
[News] Leaked documents suggest Philip Morris International's link to research activities |
Talha Burki |
|
| 2024-07-30 |
[Articles] Clinical benefit, reimbursement outcomes, and prices of FDA-approved cancer drugs reviewed through Project Orbis in the USA, Canada, England, and Scotland: a retrospective, comparative analysis |
Kristina Jenei, Arianna Gentilini, Alyson Haslam, Vinay Prasad |
|
| 2024-07-30 |
[Policy Review] NHS cancer services and systems—ten pressure points a UK cancer control plan needs to address |
Ajay Aggarwal, Richard Simcock, Pat Price, Bernard Rachet, Georgios Lyratzopoulos, Kate Walker, Katie Spencer, Tom Roques, Richard Sullivan |
|
| 2024-07-30 |
[Articles] Interpretable artificial intelligence to optimise use of imatinib after resection in patients with localised gastrointestinal stromal tumours: an observational cohort study |
Dimitris Bertsimas, Georgios Antonios Margonis, Suleeporn Sujichantararat, Angelos Koulouras, Yu Ma, Cristina R Antonescu, Murray F Brennan, Javier Martín-Broto, Seehanah Tang, Piotr Rutkowski, Martin E Kreis, Katharina Beyer, Jane Wang, Elzbieta Bylina, |
|
| 2024-07-30 |
[News] Carcinogenicity of talc and acrylonitrile |
Leslie T Stayner, Tania Carreón-Valencia, Paul A Demers, Jason M Fritz, Malcolm R Sim, Patricia Stewart, Hiroyuki Tsuda, Andres Cardenas, Dario Consonni, Laurie Davies, Sara De Matteis, Emanuela Felley-Bosco, Andrew J Ghio, Thomas Göen, Yann Grosse, Aless |
|
| 2024-07-30 |
[News] Nigeria mandates reporting of all cancer diagnoses |
Paul Adepoju |
|
| 2024-07-30 |
[News] New report from STRONG-AYA on addressing needs of adolescents and young adults with cancer in Europe |
Manjulika Das |
|
| 2024-07-30 |
[News] ESMO Gastrointestinal Cancers Congress 2024 |
Katherine Gourd |
|
| 2024-07-30 |
[Articles] Premature mortality trends in 183 countries by cancer type, sex, WHO region, and World Bank income level in 2000–19: a retrospective, cross-sectional, population-based study |
Shilpa S Murthy, Dario Trapani, Bochen Cao, Freddie Bray, Shashanka Murthy, Thomas Peter Kingham, Chandrakanth Are, André M Ilbawi |
|
| 2024-07-30 |
[Comment] Cancer and premature mortality—pushing the frontiers of cancer care |
Andrew Toyin Olagunju |
|
| 2024-07-30 |
[Comment] ImmunoPET in high-grade neuroendocrine tumours |
Francesco Giammarile, Roberto C Delgado Bolton, Fuad Novruzov, Diana Paez |
|
| 2024-07-30 |
[Articles] Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial |
Salomon Tendler, Mark P Dunphy, Matthew Agee, Joseph O'Donoghue, Rania G Aly, Noura J Choudhury, Adam Kesner, Assen Kirov, Audrey Mauguen, Marina K Baine, Heiko Schoder, Wolfgang A Weber, Natasha Rekhtman, Serge K Lyashchenko, Lisa Bodei, Michael J Morris |
|
| 2024-07-30 |
[News] New Zealand expands cancer treatment with funding boost |
Paul Adepoju |
|
| 2024-07-30 |
[Articles] Risks of adverse obstetric outcomes among female survivors of adolescent and young adult cancer in England (TYACSS): a population-based, retrospective cohort study |
Ceren Sunguc, David L Winter, Emma J Heymer, Gavin Rudge, Angela Polanco, Katherine A Birchenall, Melanie Griffin, Richard A Anderson, W Hamish B Wallace, Michael M Hawkins, Raoul C Reulen |
|
| 2024-07-30 |
[Comment] Closing the research gaps in obstetric health for survivors of cancer |
Ranjeet Bajpai, Jyoti Bajpai |
|
| 2024-07-30 |
[Articles] Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study |
Mohamad E Allaf, Se-Eun Kim, Viraj Master, David F McDermott, Lauren C Harshman, Suzanne M Cole, Charles G Drake, Sabina Signoretti, Mahmut Akgul, Nicholas Baniak, Elsa Li-Ning, Matthew B Palmer, Hamid Emamekhoo, Nabil Adra, Hristos Kaimakliotis, Yasser G |
|
| 2024-07-30 |
[Comment] Perioperative immunotherapy in renal cell carcinoma |
Delphine Borchiellini, Karim Bensalah |
|
| 2024-07-30 |
[News] Cancer priorities set out in manifestos as organisations warn of worsening standards |
Emma Wilkinson |
|
| 2024-07-30 |
[Articles] Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled p |
Philippe Moreau, Cyrille Hulin, Aurore Perrot, Bertrand Arnulf, Karim Belhadj, Lotfi Benboubker, Sonja Zweegman, Hélène Caillon, Denis Caillot, Hervé Avet-Loiseau, Michel Delforge, Thomas Dejoie, Thierry Facon, Cécile Sonntag, Jean Fontan, Mohamad Mohty, |
|
| 2024-07-30 |
[Comment] Daratumumab maintenance in patients with myeloma |
Meral Beksac |
|
| 2024-07-30 |
[Personal View] A manifesto for improving cancer detection: four key considerations when implementing innovations across the interface of primary and secondary care |
Anna Dowrick, Sue Ziebland, Tanvi Rai, Claire Friedemann Smith, Brian D Nicholson |
|
| 2024-07-30 |
[Policy Review] Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Work |
Yi Lin, Lugui Qiu, Saad Usmani, Chng Wee Joo, Luciano Costa, Benjamin Derman, Juan Du, Hermann Einsele, Carlos Fernandez de Larrea, Roman Hajek, P Joy Ho, Efstathios Kastritis, Joaquin Martinez-Lopez, Maria-Victoria Mateos, Joseph Mikhael, Philippe Moreau |
|
| 2024-06-25 |
[Clinical Picture] Painful annular skin rash on both legs in a patient with rectal cancer |
Han-Wen Lin, Chun-Yu Cheng |
|
| 2024-06-25 |
[Editorial] More needed to improve early cancer diagnosis |
The Lancet Oncology |
|
| 2024-06-25 |
[Corrections] Correction to Lancet Oncol 2024; 25: 744–59 |
|
|
| 2024-06-25 |
[Corrections] Correction to Lancet Oncol 2024; 25: 317–25 |
|
|
| 2024-06-25 |
[Corrections] Correction to Lancet Oncol 2024; 25: e205–16 |
|
|
| 2024-06-25 |
[Correspondence] Dual therapy in metastatic castration-resistant prostate cancer |
Jiaqi Huang, Fei Leng |
|
| 2024-06-25 |
[Corrections] Correction to Lancet Oncol 2021; 22: 620–31 |
|
|
| 2024-06-25 |
[Correspondence] CNS activity of trastuzumab deruxtecan in HER2-expressing non-small-cell lung cancer |
Anna-Maria Lazaratos, Kevin Petrecca, Marie-Christine Guiot, Katarzyna J Jerzak, Matthew Dankner |
|
| 2024-06-25 |
[Series] Assessment of endpoint definitions in curative-intent trials for mucosal head and neck squamous cell carcinomas: Head and Neck Cancer International Group consensus recommendations |
Annette M Lim, Lachlan McDowell, Chris Hurt, Christophe Le Tourneau, Akihiro Homma, George Shenouda, David J Thomson, Antoine Moya-Plana, Christina Henson, Petr Szturz, Andrew T Day, James E Bates, Smaro Lazarakis, Juliette Thariat, Amanda Psyrri, Hisham |
|
| 2024-06-25 |
[Comment] Randomised trials in children with rhabdomyosarcoma: time for a change? |
Ewa Koscielniak, Thomas Klingebiel |
|
| 2024-06-25 |
[Series] Assessment of endpoint definitions in recurrent and metastatic mucosal head and neck squamous cell carcinoma trials: Head and Neck Cancer International Group consensus recommendations |
Annette M Lim, Christophe Le Tourneau, Chris Hurt, Sarbani G Laskar, Conor E Steuer, Velda L Y Chow, Petr Szturz, Christina Henson, Andrew T Day, James E Bates, Smaro Lazarakis, Lachlan McDowell, Hisham Mehanna, Sue S Yom, the HNCIG |
|
| 2024-06-25 |
[Series] Criteria for the diagnosis of extranodal extension detected on radiological imaging in head and neck cancer: Head and Neck Cancer International Group consensus recommendations |
Christina Henson, Ahmad K Abou-Foul, Eugene Yu, Christine Glastonbury, Shao Hui Huang, Ann D King, William M Lydiatt, Lachlan McDowell, Alex A Nagelschneider, Paul C Nankivell, Brian O’Sullivan, Rhian Rhys, Youping Xiao, David Andrew, Jon T Asmussen, Fran |
|
| 2024-06-25 |
[Articles] Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group |
Abha A Gupta, Wei Xue, Douglas J Harrison, Douglas S Hawkins, Roshni Dasgupta, Suzanne Wolden, Barry Shulkin, Amira Qumseya, Jonathan C Routh, Tamara MacDonald, Shari Feinberg, Brian Crompton, Erin R Rudzinski, Michael Arnold, Raj Venkatramani |
|
| 2024-06-25 |
[Perspectives] Words on the Wards |
Julie R Wechsler |
|
| 2024-06-25 |
[Perspectives] Olufunmilayo Olopade—preventive oncologist using genetics to fight breast cancer in high-risk populations |
Elizabeth Gourd |
|
| 2024-06-25 |
[Perspectives] Overcoming barriers to early breast cancer presentation in Nigeria |
Mercy Ofuya |
|
| 2024-06-25 |
[Articles] Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial |
Selim Corbacioglu, Holger Lode, Susanne Ellinger, Florian Zeman, Meinolf Suttorp, Gabriele Escherich, Konrad Bochennek, Bernd Gruhn, Peter Lang, Marius Rohde, Klaus Michael Debatin, Daniel Steinbach, Andreas Beilken, Ruth Ladenstein, Rainer Spachtholz, Pe |
|
| 2024-06-25 |
[Articles] Cancer risk in people living with HIV and solid organ transplant recipients: a systematic review and meta-analysis |
Fengyi Jin, Claire M Vajdic, I Mary Poynten, Jennifer K McGee-Avila, Philip E Castle, Andrew E Grulich |
|
| 2024-06-25 |
[Series] Standardised definitions and diagnostic criteria for extranodal extension detected on histopathological examination in head and neck cancer: Head and Neck Cancer International Group consensus recommendations |
Ahmad K Abou-Foul, Christina Henson, Rebecca D Chernock, Shao Hui Huang, William M Lydiatt, Lachlan McDowell, Brian O’Sullivan, Bayardo Perez-Ordonez, Max Robinson, Paul C Nankivell, Elena Ruiz-Bravo, Simion I Chiosea, Tina M Green, Keith D Hunter, Jacque |
|
| 2024-06-25 |
[News] Four industries responsible for millions of deaths each year |
Talha Burki |
|
